Erweiterte Suche

Naveen Chopra is currently a Director at Vodafone West Ltd.
and Excel Telesonic India Pvt Ltd.
He was previously a Director at Indus Towers Ltd.
and the Chief Operating Officer at Vodafone India Ltd.
from 2004 to 2017.
He obtained an undergraduate degree from the University of Delhi.

Naveen Chopra is currently the Managing Director & Director at Primo Chemicals Ltd.
He completed his undergraduate degree and MBA from Panjab University Chandigarh.

Naveen Chopra ist Chief Financial Officer & Executive Vice President bei ViacomCBS, Inc. Er ist außerdem Mitglied des Vorstands von KQED, Inc. In seiner früheren Laufbahn war Naveen Chopra CFO-Devices & Services Business bei Amazon.com, Inc, Chief Executive & Financial Officer bei TiVo Solutions, Inc, Chief Financial Officer von Pandora Media LLC, Director-Business Development bei Ofoto, Inc. und Director-Product Marketing & Business Development bei Moxi Digital, Inc. Naveen Chopra erhielt einen Bachelor-Abschluss von der Stanford University und einen MBA von der Stanford Graduate School of Business.

Rajneesh Chopra worked as VP-Operations & Maintenance Business Group and Head-Global Business Development at VA Tech Wabag Ltd.

Gautam Chopra has founded Continuum Green Energy Ltd.
in 2009, where he currently holds the title of Vice President-Project Development.
He has worked as a Principal at HSBC Holdings Plc, Chief Operating Officer at Mission Biofuels India Pvt Ltd., and Vice President-Special Projects at ABN Amro Bank NV (India).
Mr. Chopra completed his undergraduate degree at the Indian Institute of Technology Roorkee.

Rajesh Chopra is currently the Chief Executive Officer & Director at Aethon Therapeutics, Inc. He is also a Non-Executive Director at Artios Pharma Ltd., a Director at Nereid Therapeutics, Inc., and a Venture Partner at Apple Tree Venture Management Llc.
In the past, he worked as a Director-Medical Science at AstraZeneca PLC from 2004 to 2009, an Independent Non-Executive Director at e-Therapeutics Plc from 2012 to 2015, and as the VP-Translational & Early Drug Development at Celgene Corp.
from 2009 to 2016.
He also served as the Director-Hematological Oncology Department at The Christie NHS Foundation Trust.
Dr. Chopra holds a doctorate degree from University College London and an undergraduate degree from The UCL Academy.

Dheeraj Chopra is currently a Director at Akorn India Pvt Ltd.
Prior to this, he worked as the Chief Financial & Risk Officer at Fresenius Kabi Oncology Ltd.